Dr. Ramani Rheumatology Clinic
Dr. Ramani
Rheumatology Clinic
Medication information · Biologic therapy · Type I interferon receptor blocker · Kuala Lumpur

Anifrolumab (Saphnelo)

Also known as: Saphnelo · Anifrolumab-fnia

Anifrolumab, sold as Saphnelo, is a targeted biologic used as an add-on treatment for adults with moderate to severe active systemic lupus erythematosus, also called SLE or lupus, when standard treatment is not controlling the disease well enough. In my clinic, the intravenous form is given as a planned infusion every four weeks.

Calm, careful medication review by a consultant rheumatologist.

For nurses and infusion staff

For nurses and infusion staff

These are the forms I use for intravenous Saphnelo infusions in day-care. The prescriber order form covers patient information, pre-infusion assessment, blood tests, treatment preparation and administration. The infusion chart is used to record vital signs, infusion-related symptoms, previous reactions, interventions and clinical observations. These documents are intended for trained healthcare professionals and should be completed according to institutional policy and the prescribing doctor's instructions.

Let me explain

What this medicine is

Anifrolumab is a monoclonal antibody that blocks the type I interferon receptor. Type I interferon is an immune signal that is often overactive in lupus and can contribute to inflammation in the skin, joints and other parts of the body. By blocking this signal, anifrolumab helps calm one of the important immune pathways involved in lupus. It is a targeted biologic rather than a steroid or chemotherapy medicine. For the intravenous regimen used in my clinic, Saphnelo is diluted and given through a drip into a vein over 30 minutes, usually once every four weeks.

Why this medicine may be discussed

Uses and context

I may consider anifrolumab for an adult with moderate to severe, active autoantibody-positive systemic lupus erythematosus when standard lupus treatment is not controlling the disease well enough. The decision depends on the pattern of lupus, previous treatment, current disease activity, infection risk and the organs involved. It is used alongside standard lupus treatment rather than replacing every other medicine immediately. Anifrolumab has not been adequately evaluated for severe active lupus nephritis or severe active central nervous system lupus. These situations require a different and often more urgent specialist treatment plan.

Rheumatology perspective

How this relates to rheumatology care

Anifrolumab is an add-on treatment. Before recommending it, I review your lupus symptoms, organs involved, blood-test activity, previous medicines, flare history, steroid dose, infections, vaccinations and pregnancy plans. Once treatment begins, I review your symptoms, examination findings, blood tests, flare frequency and steroid requirements over time. Response varies from person to person and is usually assessed over several months rather than after a single infusion. Please do not stop hydroxychloroquine, steroids or other lupus medicines unless I have specifically advised you to do so.

Safety checks

What safety checks may matter

Confirm the lupus diagnosis, current disease activity and organs involved

Review current lupus medicines and any other biologic or monoclonal-antibody treatment

Check for an active infection or a history of serious or recurring infections

Review previous shingles infection and vaccination history

Review influenza, pneumococcal, shingles and other suitable non-live vaccinations

Arrange baseline and ongoing blood tests according to the individual treatment plan

Discuss any history of cancer

Discuss pregnancy, plans for pregnancy and breastfeeding

Check for fever, infection symptoms or a previous infusion reaction before each infusion

When I would like you to seek help

Side effects and red flags

If you have emergency symptoms such as severe allergic reaction, breathing difficulty, chest pain, stroke-like symptoms, severe abdominal pain, vomiting blood, black stools, sudden vision loss, severe infection symptoms, or severe weakness or confusion, please seek urgent medical care first rather than waiting for a WhatsApp reply.

Fever, sweating, chills or feeling severely unwell

A new or worsening cough, breathing difficulty or shortness of breath

Burning when passing urine or needing to pass urine much more frequently

Warm, red or painful skin, or a wound that is not healing

A painful blistering rash, especially on one side of the body, which may be shingles

Swelling of the face, mouth or tongue, breathing difficulty, fainting or severe dizziness

Headache, nausea, vomiting, fatigue or dizziness during or shortly after an infusion

Tell the nurse immediately if you feel unwell during the infusion. The infusion may need to be slowed, interrupted or stopped while you are assessed.

Practical cautions

Things worth knowing day to day

The intravenous regimen in my clinic is a fixed 300 mg dose given over 30 minutes every four weeks.

The full appointment may take longer than 30 minutes because of preparation, safety checks and observation.

Contact the clinic before your infusion if you have a fever, infection, are taking antibiotics or feel significantly unwell.

Do not receive a live vaccine during treatment without first discussing it with me.

Respiratory infections, bronchitis, cough, infusion reactions and shingles are among the more commonly reported side effects.

Do not reduce or stop steroids suddenly because you feel better.

Tell other doctors, dentists and healthcare professionals that you are receiving a biologic treatment.

Discuss pregnancy or breastfeeding with me before starting treatment or as early as possible.

If you miss an infusion appointment, contact the clinic so the next dose can be planned safely.

Frequently asked

Questions patients often ask me about this medicine

Anifrolumab is used as an add-on treatment for adults with moderate to severe active systemic lupus erythematosus when standard lupus treatment is not controlling the disease well enough.

Speak with me

If your lupus remains active despite standard treatment, or anifrolumab has been suggested and you would like it explained clearly, please message my clinic. I will review your lupus pattern, previous treatment, infection risk and treatment goals with you before deciding whether it is suitable.

This page is for general education only and does not replace medical advice. Please consult a qualified healthcare professional for diagnosis and treatment. Do not start, stop, or change any medicine without advice from your doctor.